RHUMBLINE ADVISERS - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 82 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$106,000
-24.8%
36,710
-1.6%
0.00%
Q4 2019$141,000
-25.8%
37,320
+0.4%
0.00%
Q3 2019$190,000
-10.4%
37,166
+8.7%
0.00%
Q2 2019$212,000
+2.4%
34,192
+17.5%
0.00%
Q1 2019$207,000
-18.5%
29,108
-2.3%
0.00%
-100.0%
Q4 2018$254,000
-37.4%
29,781
+46.9%
0.00%0.0%
Q3 2018$406,000
-24.8%
20,267
-3.0%
0.00%0.0%
Q2 2018$540,000
+47.1%
20,892
+36.0%
0.00%0.0%
Q1 2018$367,000
-27.3%
15,367
+3.1%
0.00%0.0%
Q4 2017$505,000
+37.6%
14,912
-14.1%
0.00%0.0%
Q3 2017$367,000
+22.3%
17,353
+1.1%
0.00%0.0%
Q2 2017$300,000
-12.0%
17,163
-11.9%
0.00%0.0%
Q1 2017$341,000
+12.9%
19,472
+9.1%
0.00%0.0%
Q4 2016$302,000
+2.4%
17,853
-0.8%
0.00%0.0%
Q3 2016$295,000
+10.1%
17,993
+1.7%
0.00%0.0%
Q2 2016$268,000
+2.3%
17,693
-2.2%
0.00%0.0%
Q1 2016$262,000
-34.7%
18,087
+27.7%
0.00%0.0%
Q4 2015$401,000
+75.9%
14,167
+3.9%
0.00%0.0%
Q3 2015$228,000
-32.1%
13,637
+6.3%
0.00%0.0%
Q2 2015$336,00012,8300.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders